Lorraine V. Kalia
Lorraine Kalia received her MD/PhD and neurology residency training at the University of Toronto, Canada. She conducted a postdoctoral research fellowship at Massachusetts General Hospital, USA and a movement disorders fellowship at Toronto Western Hospital, Canada.
Currently, she is an associate professor and clinician-scientist in the Division of Neurology, Department of Medicine at the University of Toronto. She is also a senior scientist at the Krembil Research Institute of the University Health Network. She holds appointments with the University of Toronto’s Tanz Centre for Research in Neurodegenerative Diseases and Department of Laboratory Medicine and Pathobiology.
Her research program focuses on Parkinson’s disease and related movement disorders. She heads a research team focused on elucidating the critical molecular mechanisms responsible for neurodegeneration in Parkinson’s disease and identifying therapeutic agents that can modulate or target these molecular mediators of neurodegeneration. She has received research funding from the Canadian Institutes of Health Research, J. P. Bickell Foundation, Michael J. Fox Foundation for Parkinson's Research, Natural Sciences and Engineering Research Council of Canada, Ontario Brain Institute, Parkinson Canada, Parkinson's UK, and Toronto General & Western Hospital Foundation.
